Financial Performance - The company's revenue for Q1 2025 was ¥270,596,190.27, representing a 5.33% increase compared to ¥256,905,255.97 in the same period last year[4] - Net profit attributable to shareholders decreased by 11.20% to ¥1,544,654.24 from ¥1,739,546.28 year-on-year[4] - The net profit after deducting non-recurring gains and losses increased by 38.07% to ¥1,128,975.92 from ¥817,696.94 in the previous year[4] - Total operating revenue for the current period reached ¥270,596,190.27, an increase of 5.3% compared to ¥256,905,255.97 in the previous period[18] - Net profit for the current period was ¥1,964,285.37, a decrease of 19.1% from ¥2,427,205.96 in the previous period[19] Cash Flow and Assets - The net cash flow from operating activities rose by 9.67% to ¥39,057,383.54 compared to ¥35,613,948.24 in the same period last year[4] - The net cash flow from operating activities was ¥39,057,383.54, compared to ¥35,613,948.24 in the previous period, indicating an increase of 6.8%[20] - The company reported a net cash flow from investing activities of -¥36,008,467.83, an improvement from -¥50,383,705.09 in the previous period[22] - Cash and cash equivalents at the end of the period totaled ¥370,068,084.65, up from ¥336,898,188.19 at the end of the previous period[22] - The company's total assets reached ¥2,307,326,846.86, compared to ¥2,305,515,184.73 in the previous period, showing a slight increase[16] Shareholder Information - The company reported a total of 10,189 common shareholders at the end of the reporting period[8] - The largest shareholder, Yu Yangchao, holds 30.27% of the shares, totaling 36,387,628 shares[9] - The company plans to repurchase shares using between RMB 30 million and RMB 60 million, with a total of 2,346,600 shares repurchased, accounting for 1.99% of the total share capital[12] - The company has completed the share repurchase plan as of the reporting period[12] - The company aims to enhance investor confidence and align interests through the share repurchase program[12] Equity and Liabilities - Total assets at the end of the reporting period were ¥2,307,326,846.86, a slight increase of 0.08% from ¥2,305,515,184.73 at the end of the previous year[4] - Shareholders' equity attributable to the parent company increased by 0.29% to ¥1,496,358,459.85 from ¥1,492,022,748.07 at the end of the previous year[4] - The company's total liabilities were RMB 783,179,491.98, slightly down from RMB 786,123,172.76 at the beginning of the period[15] - The equity attributable to shareholders of the parent company was ¥1,496,358,459.85, up from ¥1,492,022,748.07, reflecting a growth of 0.2%[16] Earnings Per Share - The basic earnings per share decreased by 50.00% to ¥0.01 from ¥0.02 in the same period last year[4] - Basic and diluted earnings per share for the current period were both ¥0.01, down from ¥0.02 in the previous period[20] Operating Costs - Total operating costs amounted to ¥271,307,730.48, up from ¥257,780,429.22, reflecting a rise of 5.2%[18] Asset Composition - The company's current assets totaled RMB 602,163,314.71, up from RMB 579,976,110.79 at the beginning of the period[13] - The company's non-current assets decreased from RMB 1,725,539,073.94 to RMB 1,705,163,532.15 during the same period[13] - The company's cash and cash equivalents increased to RMB 373,324,620.90 from RMB 361,137,972.25[13] - Accounts receivable rose to RMB 20,004,757.55 from RMB 16,696,728.60, indicating a growth in receivables[13]
华绿生物(300970) - 2025 Q1 - 季度财报